In our recent work, we showed neuronal nitric oxide synthase 1 (NOS1 or nNOS) to be translationally regulated by FMRP in the fetal human neocortex and severely reduced in the fetal and post-natal developing neocortex of FXS patients (Kwan et al., 2012a). The gene discussed is FMR1; the disease is fragile X syndrome.